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Abstract
Mutations in LRRK2 are genetically linked to Parkinson’s disease (PD) but its normal biological function is largely unknown.
Sheng et al. recently reported that deletion of the WD40 domain of LRRK2 in zebrafish specifically causes PD-like loss of
neurons and behavior defect. However, our similar early study and recent confirming experiments using the same reagents
reported by Sheng et al. failed to reproduce the phenotype of the loss of dopaminergic neurons, although the mRNA of
LRRK2 was molecularly disrupted. Our study suggests that function of LRRK2 and its usefulness to generate zebrafish PD
model needs further evaluation.
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Introduction
Parkinson’s disease (PD) is a common neurodegenerative dis-
order affecting approximately 1% of the population over the age of
50[1]. The primary symptoms of PD are movement dysfunctions,
including tremor, rigidity, bradykinesia, and postural instability[2].
The pathologic hallmarks of PD are loss of dopaminergic (DA)
neurons in the substantia nigra (SN) and the presence of Lewy
bodies in the brain. Although most PD patients are idiopathic,
5–10% of PD patients are diagnosed to be linked to certain gene
mutations, such as a-synuclein, UCHL1, LRRK2 (Leucine-rich
repeat kinase 2), PINK1, Parkin, DJ-1, and ATP13A2[3]. Among
these genes, LRRK2 represents the most prevalent genetic cause
of autosomal-dominant PD[4,5,6,7].
Human LRRK2 encodes a huge protein of 2527 amino acid
and contains several functional domains including ARM (Arma-
dillo), ANK (Ankyrin repeat), LRR (Leucine rich repeat), Roc (Ras
of complex proteins, GTPase), COR (C-terminal of Roc),
MAPKKK (Mitogen activated kinase kinase kinase), and WD40
from the N-terminus to the C-terminus. Over 40 point mutations
have been identified in LRRK2, covering all of the functional
domains, but proven pathogenic mutations appear concentrated
in the GTPase and kinase domains[3,8]. The most common
pathogenic mutation is G2019S in the kinase domain, which is
identified in ,1% sporadic PD patients and ,4% familial PD
patients [9]. Overexpression of pathogenic variants of LRRK2 is
toxic in cultured neuronal cells[10,11]. In vitro kinase activity assay
using moesin as substrate showed mutation G2019S increased the
kinase activity of LRRK2, implying that the hyper kinase activity
of LRRK2 is the cause of PD[12]. In transgenic mice, overex-
pression of mutant LRRK2
R1441G resulted in age-dependent and
levodopa-responsive slowness of movement while overexpression
of wild type LRRK2 did not cause typical symptom of PD [13]. In
another study, overexpression of LRRK2
G2019S caused decreases
in striatal dopamine content, release, and uptake[14]. However,
the most characteristic feature of PD, loss of DA neurons, was not
observed in these transgenic mice. Also, transgenic overexpession
does not address the loss of function issue of LRRK2, which is
critical for providing information of its normal biological function.
Zebrafish is a well established animal model for studying human
diseases and has been used to investigate PD[15]. In addition,
zebrafish embryos are susceptible to the treatment by the classic
dopaminergic neurotoxin MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tet-
rahydropyridine), which causes loss of DA neurons in zebrafish
embryonic diencephalon, mimicking the key feature of PD
[16,17]. Recently, Sheng et al. reported a functional study of
LRRK2 in zebrafish, showing that deletion of the WD40 domain
of zebrafish LRRK2 produced typical PD phenotype including
specific loss of DA neurons and locomotive defect without overall
developmental defect[18]. We have also been investigating
LRRK2 function in zebrafish prior to Sheng et al. ’s publication
but were not able to observe the reported phenotype. In more
recent studies, we further confirmed that the DA neurons appear
normal in embryos with depletion of LRRK2 mRNA by injection
of the exact same morpholino oligos (MOs) reported by Sheng et
al. Our studies suggest that function of LRRK2 and its usefulness
to generate zebrafish PD model needs further evaluation.
Results and Discussion
Design and validation of MOs targeting LRRK2
Bioinformatics analysis of genome sequence revealed that
zebrafish contains a single copy of highly conserved LRRK2
homolog (Ensembl ENSDARG00000006169) that has all of the
functional domains[18]. We observed similar expression pattern of
LRRK2 as reported by Sheng et al. To study the function of
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were designed to disrupt the splicing of kinase and WD40 domains
of LRRK2 (Fig. 1). To determine whether these three MOs did
not produce the reported phenotype due to the difference of
targeting sites, the two exact RNA splice-blocking MOs (IE and
EI) used by Sheng et al. were tested and re-named as MO51IE and
MO51EI, respectively in this paper. Our MO51IE’ is one
nucleotide upstream to MO51IE and to make comparison concise,
the data of MO51IE’ is not shown.
The efficiency of these MOs was evaluated by RT-PCR with
primers flanking the MO target sites at 3 dpf (days post
fertilization) embryos (Fig. 1). At a dose of 8 ng per embryo, all
MOs were able to block the normal splicing of zebrafish LRRK2,
leading to exon deletion (Fig. 2A, bands a to c). Co-injection of
MO51IE+MO51EI resulted in dramatic decrease of wild type
LRRK2 transcript (Fig. 2A, band c), confirming the efficacy of
molecular knockdown of LRRK2 mRNA by MOs used by Sheng
et al. To further determine whether there was drastic nonsense
mediated decay of LRRK2 transcripts, a quantitative PCR test
was performed using primers flanking region 59-upstream to MO
target sites, which are as same as Sheng et al. used, and no obvious
decay of LRRK2 transcripts was detected in morphant groups, at
least 60% LRRK2 transcripts remaining (Fig. 2B), while the level
of LRRK2 in MO51EI+MO51IE group was statistically signifi-
cant lower than that in control group (F(3, 8) =4.35, P,0.05).
The aberrant transcript variants contained reading frame shifts
and premature stop codons within the kinase or WD40 domain,
implying the presence of putative truncated proteins.
Knockdown of LRRK2 does not cause loss of DA neurons
in zebrafish embryo
The MOs were injected into zebrafish embryos at a series of
doses (Table 1). Most morphants developed 4-hour slower than
un-injected control embryos without notable morphological defect
at the dose of 8 ng per embryo or lower. We used 8 ng per embryo
for experiments of this report since this concentration produced
efficient block of LRRK2 mRNA splicing, as shown in Figure 2.
At 3 dpf, in situ hybridization with dat (dopamine transporter)
probe was performed to detected DA neurons[19]. For each of
these MOs or MO combination, we did not observe loss of DA
neurons in morphants (Fig. 3). Although MO50 and MO51IE
+MO51EI caused some irregular patterns of DA neurons in
diencephalons, specific loss of DA neurons was still not observed
(Fig. 3J, K, L and M).
In our studies of PD with zebrafish, we prefer using dat as probe
to detect DA neurons since it is the most specific marker for
DA neurons. However, Sheng et al. mainly used th (tyrosine
hydroxylase) as probe to detect DA neurons in their report. To be
consistent with their studies, we performed the same in situ
hybridization using th probe and, again, no loss of DA neurons was
observed in morphants (Fig. 4). There should be no difference
between dat and th in detecting DA neurons because both of them
are well established marker genes for PD studies [19,20].
We also examined the locomotor phenotype of morphants and
used their un-injected siblings as control. Locomotor experiments
included tactile response test at 3 dpf and swimming ability assay
at 6 dpf. Consistent with our in situ hybridization result with either
dat or th probe, there were not obvious differences between control
and morphant (Fig. S2).
Loss of function study of LRRK2 homologs in C. elegans,
Drosophila, and mouse has been carried out. In C. elegans, lrk-1
(LRRK2 homolog) regulates axonal-dendritic polarity of SV
proteins, stress response and neurite outgrowth, but does not
affect DA neurons[21,22]. In Drosophila, two groups reported
contrasting findings: Lee et al. reported that loss of LRRK
(LRRK2 homolog) induced severe reduction of DA neurons[23],
while Wang et al. reported that the LRRK mutant fruit fly
developed normally without changing the number and pattern of
DA neurons[24]. In LRRK2 knockout mouse, the dopaminergic
system appeared intact in both young and aged mice. Further-
more, there was no significant difference in the susceptibility of
LRRK2 knockout and wild type mice to MPTP[25]. Collectively,
the findings in model animals suggest that LRRK2 plays a very
limited role in the development or maintenance of DA neurons[7].
In conclusion, our study indicates that disruption of LRRK2 in
zebrafish did not lead to loss of DA neurons. Considering the
limitations of knockdown with antisense morpholino oligo and the
importance of LRRK2 gene, to obtain a more solid conclusion of
the function of LRRK2 in embryonic development and generation
Figure 1. Schematic representation of the target sites of the morpholino oligos and the positions of the primers used in RT-PCR. The
morpholino oligos target Exon 45 (E45), Exon 50 (E50) and Exon 51 (E51), which correspond to the coding sequences of Kinase, WD40 and WD40
domain respectively. Exon 51, shown as E51 (45), is the same as Exon 45 described by Sheng et al. The morpholino oligos and their corresponding
primers are indicated by the same color.
doi:10.1371/journal.pone.0020630.g001
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nucleases to inactivate LRRK2 in zebrafish in future study.
Materials and Methods
Zebrafish maintenance
Wild type AB was maintained in a circulating aquaculture sys-
tem according to standard described in The Zebrafish Book[26].
Embryos were incubated at 28.5uC and staged according to the
description by Kimmel et al[27]. At 24 hours post fertilization,
1-phenyl-2-thiourea (PTU, Sigma-Aldrich, St. Louis, MO,) was
added to a final concentration of 0.003% to prevent the pro-
duction of pigment. This zebrafish study was approved by Peking
University Shenzhen Graduate School (09316).
Design and injection of morpholino oligos
Five morpholino oligos were obtained from Gene Tools (Philo-
m a t h ,O R ) .T h e ya r e :M O 4 5 ,5 9CCCCTTCAGTATAAAAACA-
CACTGT39, targeting putative intron 44/exon 45 boundary; MO50,
59AAATCTGCATGTTTTAGCACCTGGT39, targeting putative
exon 50/intron 50 boundary; MO51IE’, 59AGCTCCTGAAACA-
CAGCATTAGGAA39, targeting putative intron 50/ exon 51 boun-
Figure 2. The splicing of lrrk2 mRNA was interrupted by the morpholino oligos. The injection dose of the morpholino oligos was 8 ng each
per embryo. A, RT-PCR with cDNA of 3 dpf embryos (control and morphant) confirmed the blockage of normal splicing. The aberrant splice products
(band a, b and c in A) were cloned and sequenced.The slash lines indicate the deletion of exons. All of the aberrant mRNA variants have reading frame
shifts and pre-mature stop codons, and produce putative truncated LRRK2 proteins in the corresponding domains shown in Figure 1. In the lanes of
MO50 morphant and MO51EI+MO51IE morphant, almost no wild type LRRK2 mRNA was present. B, qPCR using primers flanking the region upstream
to MO target sites shows at least 60% LRRK2 transcripts can be detected, indicating no obvious nonsense mediated decay of LRRK2. Data were shown
as mean6S.E.M of biological triplicates from at least two independent experiments and were presented as fold changes in relative gene expression as
compared with control after being normalized to beta-actin. The relative fold changes were calculated by a comparative Ct method. P..0.05
between control, MO45, and MO50 group; P , 0.05 between control and MO51EI+MO51IE group.
doi:10.1371/journal.pone.0020630.g002
Table 1. Injection doses of morpholino oligos.
Morpholino oligos Dose (ng per embryo) Phenotype at 3 dpf
MO45 8, 10 8 ng group, 109 embryo alive, 12 embryo dead; 10 ng group, 148 embryo alive, 14 embryo
dead. Live embryos developed about 4 hours slower than control.
MO50 6, 8, 10 6 ng group, 133 embryo alive, 16 embryo dead; 8 ng group, 108 embryo alive, 7 embryo dead;
10 ng group, 123 embryo alive, 14 embryo dead. Live embryos developed about 4 hours slower
than control. In 10 ng group, 12 embryos had defects in head and heart.
MO51IE+MO51EI 8+8 129 embryo alive, 15 embryo dead. Live embryos developed about 4 hours slower than control.
doi:10.1371/journal.pone.0020630.t001
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targeting putative intron 50/ exon 51 boundary; MO51EI, 59CAC-
AA GCAGATTTATTAACCTGTGC39, targeting putative exon
51/intron 51 boundary. These morpholino oligos were dissolved in
R N a s ef r e ed d H 2O and microinjected by a PLI-90 microinjector
(HARVARD APPARATUS, Holliston, MA) into one-cell fertilized
egg. The volume of injection was calibrated using a glass capillary of
1 ml. The length of the glass capillary is 34 mm. By measuring the
Figure 3. RNA whole mount in situ hybridization of 3 dpf embryos with dat probe didn’t show significant loss of DA neurons in
morphant. E to H, L and M, enlargement of the area of DA neurons in A to D, J, and K, respectively. The numbers on bottom right corner showed
number of the embryos with a certain phenotype/number of total embryos in that group. The patterns of DA neurons in most embryos were normal,
while some were disorganized. I, the quantitative result of dat positive neurons in the diencephalon. There is no significant DA neuron loss in
morphant group. n=20 in each group, P..0.05 in all comparisons.
doi:10.1371/journal.pone.0020630.g003
Figure 4. RNA whole mount in situ hybridization of 3 dpf embryos with th probe didn’t show significant loss of DA neurons in
LRRK2 morphants. A to D, the diencephalon region of zebrafish embryos, dorsal view, anterior to the top. The numbers on bottom right corner
showed number of the embryos with a certain phenotype/number of total embryos in that group. There was not obvious alteration of DA neurons
pattern in the diencephalon of the morphants (B, C, and D). E, quantative result of th positive neurons in the diencephalon. There was not significant
DA neurons loss in all three morphant groups. n=20 in each group, P..0.05 in all comparisons.
doi:10.1371/journal.pone.0020630.g004
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per injection was thereby calculated, then the corresponding amount
of MOs was also calculated. Injected embryos (morphant) were
cultured in fish water at 28.5uCa n da l l o w e dt og r o wu pt o6d a y s .
RT–PCR
Total RNA was isolated with RNAqueous
H-4PCR Kit (Ambion,
Austin, TX) from 3 dpf embryos and cDNAs were generated with
PrimeScript
TM RT reagent Kit (Takara, Dalian, China). Primers
flanking target site were used to evaluate the efficacy of the each
morpholino oligos. For MO45, the primers were F45-59 GAGA-
CGCTGCTGAAGAAA39 (5386-5403) and R45-59 CGAACT-
CACTGGGAAACT 39 (6221–6238). For MO50, the primers
were F50-59 ATGTTTATTCGTTCGGTCTG39 (6152–6171)
and R50-59 AGTGTCCCGTCTGCTGTG 39 (6804–6821). For
MO51IE’, MO51IE and MO51EI, the primers were F51-
59TGCAAACGGAGGTAAAAACC39 (6474–6493) and R51-
59AGATGATCCTGGTCCCACAG39 (6960–6979), which were
the same as those used by Sheng et al[18]. The products were
amplified by Taq PCR MasterMix (Tiangen, Beijing, China). The
procedure of PCR was as following: 94uC for 5 min; 35 cycles of
94uC for 30 sec, 55uC for 30 sec and 72uC for 1 min; 72uC for 7
min; 16uC, forever. The PCR products were cloned into pGEM-
Teasy vector (Promega, Madison, WI) for sequencing.
Quantitative PCR
30 embryos of each group at 3 dpf were harvested. Total RNA
was isolated with RNAqueous
H-4PCR Kit (Ambion, Austin, TX)
and cDNAs were generated with PrimeScript
TM RT reagent Kit
(Takara, Dalian, China). For LRRK2, the primers were as
follows: 59GACTCCGAGGCGATACAG39 (forward, 778–795)
and 59CAAGGGCACTCAGACAGG39 (reverse, 935–952); for
beta-actin, the primers were as follows: 59 GCCGTGACCT-
GACTGACTACCT39 (forward) and 59 CGCAAGATTCCA-
TACCCAAGA39 (reverse). Quantitative PCR was carried out
on a 7300 real time PCR system (Applied Biosystems, Carlsbad,
CA) with SYBR
H PrimeScript
H RT-PCR Kit (Takara, Dalian,
China). Presented data were shown as mean6S.E.M of
biological triplicates from at least two independent experiments
and were presented as fold changes in relative expression as
compared with control after being normalized to beta-actin. The
relative fold changes were calculated by a comparative
Ct method[28].
Whole mount in situ hybridization and counting DA
neurons
Digoxigenin-labeled anti-sense RNA probes were generated in
vitro by using the zebrafish dat and th cDNA as templates with RNA
polymerase (Promega, Madison, WI). Whole-mount RNA in situ
hybridizations were performed essentially as described by Wester-
field[26]. After in situ hybridization, transfer embryos into glycerol
and equilibrate for 10 min. Then put it on a slide and flatten it
softly with a cover slip to disperse the neurons (Fig. S1). The
number of dat or th positive neurons in the diencephalon region
was counted manually by two persons blinded to the knockdown
of LRRK2.
Imaging
Pictures of zebrafish embryos were taken with AxioImager A1
microscope and AxioCam digital camera (Zeiss, Oberkochen,
Germany), and edited with Photoshop 7.0 (Adobe systems, San
Jose, CA).
Behavior assay
Tactile response assay of 3 dpf embryo was modified from Xi
et al., 2010[29]. Embryos in a 10 cm-diameter petri dish were put
in the centre of a 3.5 cm field of a dissecting microscope (Zeiss,
Oberkochen, Germany). Gently touched the tail of embryo with a
forcep and recorded manually the times of touch to drive the
embryo out of the field. Swimming ability assay of 6 dpf embryo
was modified from Levin and Cerutti, 2009[30]. An embryo was
put in a well (diameter=3.5 cm) containing 3 ml fish water and
being divided equally to 8 parts, accommodated for 10 min, then
manually recorded the times of segment crossing to different parts
by an embryo within 5min.
Statistical analysis
All statistical analysis was performed with SPSS. The compar-
isons of differences between control and morphant groups were
performed using one-way ANOVA. When the P value was less
than 0.05, a Tukey HSD pairwise comparison post hoc test was
conducted to determine the significance of difference between
control and morphant groups. Error bars represented 6 S.E.M.
The number of used embryo was shown in the corresponding
figure legend. All experiments were independently repeated at
least three times. P values less than 0.05 were considered to be
significant.
Supporting Information
Figure S1 Flatten embryo and count DA neurons. Take
embryos hybridized with dat probe as an example. After in situ
hybridization, transfer embryos into glycerol and equilibrate for 10
min. Then put it on a slide and flatten it softly with a cover slip to
disperse the neurons (A, dosal view; B, lateral view). C and D show
the same embryo before and after being flattened.
(TIF)
Figure S2 Behavioural assay showed morphant group
embryos were normal in locomotor behavior. A, result of
tactile respone of 3 dpf embryo. n=20 in each group, P..0.05.
B, result of swimming ability of 6 dpf embryo. n=20 in each
group, P..0.05.
(TIF)
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